Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study

Fernanda Lima-Setta,Maria Clara de Magalhães-Barbosa,Gustavo Rodrigues-Santos,Elaine Augusta das Neves Figueiredo,Melissa de Lorena Jacques,Raquel de Seixas Zeitel,Roberto Sapolnik,Cibelle Teixeira da Siva Borges,Vanessa Soares Lanziotti,Roberta Esteves Vieira de Castro,Ana Paula Novaes Bellinat,Thiago Peres da Silva,Felipe Rezende Caino de Oliveira,Bárbara Carvalho Santos Dos Reis,Natália Almeida de Arnaldo Silva Rodriguez Castro,João Henrique Garcia Cobas Macedo,Ana Carolina Cabral Pinheiro Scarlato,Paula Marins Riveiro,Isabele Coelho Fonseca da Mota,Vivian Botelho Lorenzo,Natalia Martins Lima de Lucena,Zina Maria Almeida de Azevedo,Antonio José L A Cunha,Arnaldo Prata-Barbosa,Brazilian Research Network in Pediatric Intensive Care (BRnet-PIC)

DOI: https://doi.org/10.1016/j.jped.2020.10.008

Abstract:Objective: To describe the clinical, laboratory, and radiological characteristics, as well as the outcomes of children with MIS-C. Method: Multicenter, prospective cohort study, conducted in 17 pediatric intensive care units in five states in Brazil, from March to July 2020. Patients from 1 month to 19 years who met the MIS-C diagnostic criteria were included consecutively. Results: Fifty-six patients were included, with the following conditions: Kawasaki-like disease (n = 26), incomplete Kawasaki disease (n = 16), acute cardiac dysfunction (n = 10), toxic shock syndrome (n = 3), and macrophage activation syndrome (n = 1). Median age was 6.2 years (IQR 2.4-10.3), 70% were boys, 59% were non-whites, 20% had comorbidities, 48% reported a contact with COVID-19 cases, and 55% had a recent SARS-CoV-2 infection confirmed by RT-PCR and/or serology. Gastrointestinal symptoms were present in 71%, shock symptoms in 59%, and severe respiratory symptoms in less than 20%. d-Dimer was increased in 80% and cardiac dysfunction markers in more than 75%. Treatment included immunoglobulin (89%); corticosteroids, antibiotics, and enoxaparin in about 50%; and oseltamivir and antifungal therapy in less than 10%. Only 11% needed invasive mechanical ventilation, with a median duration of five days (IQR 5-6.5). The median length of PICU stay was six days (IQR 5-11), and one death occurred (1.8%). Conclusions: Most characteristics of the present MIS-C patients were similar to that of other cohorts. The present results may contribute to a broader understanding of SARS-CoV-2 infection in children and its short-term consequences. Long-term multidisciplinary follow-up is needed, since it is not known whether these patients will have chronic cardiac impairment or other sequelae.